For a company developing a technology intended to reduce noise, BioSig Technologies (OTCQB: BSGM) (Minneapolis) has been anything but quiet this year. The company is getting ready to seek FDA clearance for its Pure EP system, a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system. Read More
